Sign in
4

Changes in Ownership

Denali Therapeutics Inc. Filed Acc 0001714899-22-000129

President and CEO sold 2,404 shares at $33.22 ($79,861)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Watts Ryan J. President and CEO 2022-08-19 Sale −2,404 $33.22 $79,861 2,202,993 I
Open-market sales · 2,404 sh · avg $33.22 · $79,861
Loading xslF345X03/wf-form4_166128769265555.xml…